https://www.nxtpsychedelics.com/news/articles/public-companies/atai-life-sciences-and-massachusetts-general-hospital-announce-initiation-of-clinical-study-investigating-neuroplasticity-biomarkers-in-treatment-resistant-depression-patients-undergoing-ketamine-trea/